Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Cancer Prevention Month: Get ACRO Health Gift Cards! Cancer Prevention Month: Get ACRO Health Gift Cards!
Fill out organ-on-a-chip questionnaire to win a FREE gift! Fill out organ-on-a-chip questionnaire to win a FREE gift!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Kat. Nr. | Arten | Produktbeschreibung | Struktur | Reinheit | Merkmal |
---|---|---|---|---|---|
GIR-H82E1 | Human | Biotinylated Human GITR / TNFRSF18 Protein, His,Avitag™ (MALS verified) |
|
||
GIR-C52H6 | Canine | Canine GITR / TNFRSF18 Protein, His Tag |
|
||
GIR-H82F7 | Human | Biotinylated Human GITR / TNFRSF18 Protein, Fc,Avitag™ |
|
||
GIR-H525a | Human | Human GITR / TNFRSF18 Protein, Mouse IgG2a Fc Tag, low endotoxin |
|
||
GIR-H5254 | Human | Human GITR / TNFRSF18 Protein, Fc Tag |
|
||
GIR-C5255 | Rhesus macaque | Rhesus macaque GITR / TNFRSF18 Protein, Fc Tag |
|
||
GIR-R5222 | Rat | Rat GITR / TNFRSF18 Protein, His Tag |
|
||
GIR-M5220 | Mouse | Mouse GITR / TNFRSF18 Protein, His Tag | |||
GIR-H5228 | Human | Human GITR / TNFRSF18 Protein, His Tag (MALS verified) |
|
Immobilized Canine GITR, His Tag (Cat. No. GIR-C52H6) at 2 μg/mL (100 μL/well) can bind Human GITR Ligand, Fc Tag (Cat. No. GIL-H526a) with a linear range of 2-40 ng/mL (QC tested).
The purity of Biotinylated Human GITR Protein, His,Avitag (Cat. No. GIR-H82E1) is more than 95% and the molecular weight of this protein is around 20-30 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
BMS-986156 | BMS-986156 | Phase 2 Clinical | Bristol-Myers Squibb Company | Solid tumours; Liver Neoplasms; Thoracic Neoplasms; Neoplasms; Lung Neoplasms | Details |
MK-4166 | MK-4166 | Phase 1 Clinical | Merck & Co Inc | Solid tumours | Details |
Anti-GITR antibody (BMS) | Phase 1 Clinical | Bristol-Myers Squibb Company | Neoplasms | Details | |
Ragifilimab | INCAGN-1876; INCAGN-01876; AGEN-1876; CM-701 | Phase 2 Clinical | Agenus Inc, Ludwig Institute For Cancer Research | Neoplasms; Neoplasm Metastasis | Details |
GWN-323 | GWN-323 | Phase 1 Clinical | Novartis Pharma Ag | Solid tumours; Lymphoma | Details |
REGN-6569 | REGN-6569; REGN6569 | Phase 1 Clinical | Regeneron Pharmaceuticals Inc | Squamous Cell Carcinoma of Head and Neck | Details |
This web search service is supported by Google Inc.